Evidence map›Paper›PMID 39157626›Full record

ArticleEJHaem2024

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma.

Abdullah N M Alqahtani, Sandrine Jayne, Matthew J Ahearne, Christopher S Trethewey, Sai S Duraisingham, Susann Lehmann, Caroline M Cowley, Martin J S Dyer, Harriet S Walter

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdullah N M AlqahtaniThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.
Sandrine JayneThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.ORCID https://orcid.org/0000-0003-1870-9782
Matthew J AhearneThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.
Christopher S TretheweyThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.
Sai S DuraisinghamDepartment of Immunology University Hospitals Leicester Leicester UK.
Susann LehmannInstitute for Precision Health, Leicester Drug Discovery and Diagnostics, University of Leicester Leicester UK.
Caroline M CowleyDepartment of Genetics and Genome Biology Leicester Molecular Diagnostics Leicester Cancer Research Centre, University of Leicester Leicester UK.
Martin J S DyerThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.
Harriet S WalterThe Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester Leicester UK.ORCID https://orcid.org/0000-0003-2618-711X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39157626
PMCPMC11327755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.